Tell us what's important to you. We'll build you a better ClevelandClinic.org.

close

Take the ClevelandClinic.org Improvement Survey Now!

Online Health Chat.Access Our A-Z Phone Directorybenefiting the communityOnline Health Chat.

Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)

Print this ContentEmail this Content
Study:

Boston Scientific EPI: A Carotid Stenting Trial for High-Risk Surgical Patients

Rationale:

n/a

Purpose:

The purpose of this study is to determine whether morbidity and mortality for high-risk surgical patients treated with the Carotid Wallstent in conjunction with the FilterWire EX and EZ System distal protection device will be less than or equal to that of objective performance criteria (OPC) derived from historic controls undergoing surgical intervention with a carotid endarterectomy (CEA).

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Carotid Artery Diseases
Stroke
Cerebral Arteriosclerosis		 Device: WALLSTENT® Endoprosthesis™ N/A

Verified by Boston Scientific Corporation August, 2008

Sponsored by: Boston Scientific Corporation
Information provided by: Boston Scientific Corporation
ClinicalTrials.gov identifier: NCT00316108

Study Type: Interventional

Study Design: Treatment, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study

Cleveland Clinic & Foundation
Cleveland, Ohio 44195
United States

Christopher White, MD., Principal Investigator
Sriram Iyer, MD., Principal Investigator
Pamela G Grady, Ph.D., Study Director

This information is abbridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.